No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: A retrospective cohort study. Article uri icon

Overview

publication date

  • February 27, 2024

Research

keywords

  • Breast Neoplasms
  • Genital Neoplasms, Female
  • Skin Diseases
  • Spironolactone

Identity

PubMed Central ID

  • PMC11095997

Scopus Document Identifier

  • 85188456758

Digital Object Identifier (DOI)

  • 10.1016/j.jaad.2024.02.030

PubMed ID

  • 38423468

Additional Document Info

volume

  • 90

issue

  • 6